Topics
Medulloblastoma | Treatment | Chemotherapy | Thiotepa
Home > Publications > Topics > Medulloblastoma > Treatment > Chemotherapy > Thiotepa
Larrouquere L, Dufour C, Faure-Conter C, Alapetite C, Meyronet D,
Bolle S, Bonneville-Levard A, Sunyach MP, Laurence V, Frappaz D.
Intensive pediatric chemotherapy
regimen (PNET HR+5) in adult high-risk medulloblastoma and
pineoblastoma patients.
Neurooncol
Adv. 2024 Aug 10;6(1):vdae141. doi:
10.1093/noajnl/vdae141. PMID:
39620201. Observational study. ˍ
Erker C, Mynarek M, Simbozel M, Craig BT, Harrod VL, Cappellano
AM, Cohen KJ, Lopez VS, Morales-La Madrid A, Cacciotti C, Baroni
L, Salloum R, Margol AS, Michaiel G, Aguilera D, Mazewski CM,
Kline CN, Finlay JL, Abdelbaki MS, Murray JC, Dorris K, Crooks B,
Ginn KF, Amayiri N, Tippelt S, Fleischhack G, Tonn S, Gerber NU,
Lassaletta A, Hansford JR, Khan S, Gilheeney SW, Hoffman LM,
Zapotocky M, Larouche V, Shah S, Ramaswamy V, Gajjar A, Perreault
S, Mueller S, Hukin J, Cheng S, Wang ZJ, Matheson K, Bailey S,
Bouffet E, Clifford SC, Robinson G, Dufour C, Rutkowski S,
Lafay-Cousin L.
Salvage therapies for
first relapse of SHH medulloblastoma in early childhood.
Neuro
Oncol. 2025 Apr 4:noaf092. doi:
10.1093/neuonc/noaf092. PMID:
40186336. Observational study. ˍ